Results 121 to 130 of about 27,818 (210)
DDX17 promotes DENV-2 replication via interaction with viral dsRNA and G3BP1
Dengue virus (DENV) is one of the major arboviruses that pose a serious threat to global human health. However, there is currently no specific antiviral drug available for the treatment of DENV infection. DDX17, a member of the DExD/H-box helicase family, has been implicated in the replication processes of various viruses. Our research group discovered
Peijun Han +10 more
openaire +3 more sources
Dengue virus (DENV) serotype-2 was detected in the South Pacific region in 2014 for the first time in 15 years. In 2016–2020, DENV-2 re-emerged in French Polynesia, Vanuatu, Wallis and Futuna, and New Caledonia, co-circulating with and later replacing ...
Catherine Inizan +18 more
doaj +1 more source
Identifying the strains of dengue circulating in the western province of Sri Lanka during 2019-2022.
A study conducted from July 2019 to May 2022 at several hospitals in the Western Province, Sri Lanka, focused on dengue virus strains during the COVID-19 pandemic. Among 417 febrile patients, 47% were PCR-positive for dengue.
Harshi Abeygoonawardena +15 more
doaj +1 more source
Temporal-Spatial of dengue virus (DENV) analyses have been performed in previous epidemiological studies in mainland China, but few studies have examined the whole genome of the DENV.
Hao Zhang +5 more
doaj +1 more source
In the last few decades, dengue has become much more commonplace worldwide, and it is quickly spreading to other countries. As of right now, supportive care is the only available treatment for dengue infection as there are no approved antivirals. Although a DENV vaccine has recently been used in some countries, its indication is limited due to risk of ...
Noor Zarina Abd Wahab, Nazlina Ibrahim
openaire +1 more source
A NEW COPPER (II)-IMIDAZOLE DERIVATIVE EFFECTIVELY INHIBITS REPLICATION OF DENV-2 IN VERO CELL
Dengue is a kind of infectious disease that was distributed in the tropical and sub-tropical areas. To date, there is no clinically approved dengue vaccine or antiviral for humans, even though there have been great efforts towards this end. Therefore, finding the effective compound against dengue virus (DENV) replication is very important.
Teguh Hari Sucipto, .- +9 more
openaire +3 more sources
There are four distinct antigenic serotypes of dengue viruses (DENV-1-4). Sequential infections with different serotypes lead to cross-reactive but also serotype-specific neutralizing antibody responses.
Heidi Auerswald +9 more
doaj +1 more source
Objectives: To genotypically characterize dengue virus (DENV) isolates among dengue-infected children from 2012–13/2014–15 outbreaks in southern India.
Syed Fazil Ahamed +7 more
doaj +1 more source
BackgroundDengue virus (DENV) infection, spread by Aedes aegypti mosquitoes, is a significant public health concern in tropical and subtropical regions.
Md. Shohel Hossain +16 more
doaj +1 more source
Dengue virus (DENV) is the most widespread arthropod-borne virus, and the number and severity of outbreaks has increased worldwide in recent decades. Dengue is caused by DENV-1, DENV- 2, DENV-3 and DENV-4 which are genetically distant.
Leandra Barcelos Figueiredo +7 more
doaj +1 more source

